ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
暂无分享，去创建一个
Guo-Dong Lu | Ji Feng | Yong Wu | T. Peng | Guang-zhi Zhu | Xinping Ye | Xiao-wei Huang | Pei-zhi Lu | Zhong-jie Li | Jing Zhou | Chuangye Han | Hui-qi Dai | Pan-hong Chen | Wen-jing Su | Shing Chung Hooi | Guangzhi Zhu | S. C. Hooi